MedTrace Logo

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

NCT06041594 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2025-10-02

No results posted yet for this study

Summary

This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ System and the Malibu Aspiration Catheter™ System. These devices are manufactured by Innova Vascular, Inc.

Conditions

Interventions

DEVICE

Laguna Thrombectomy System

Removal of clot using the Laguna Thrombectomy System to treat Pulmonary Embolism

Sponsors & Collaborators

  • Innova Vascular, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-19
Primary Completion
2026-03-31
Completion
2026-04-30
FDA Device
Yes

Countries

  • United States
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06041594 on ClinicalTrials.gov